Evidence map›Paper›PMID 40950841›Full record

ArticleNursing (Auckland, N.Z.)2025

Protocol for a Pilot Randomized Controlled Trial of a Resilience Intervention Adapted for Older People Living with HIV: Resilience Intervention for Successful Aging Enhancement (RISE+).

Pariya L Fazeli, David E Vance, Jeremy D Delgadillo, Shakaye R Haase, Crystal Chapman Lambert, Brittany L Bradley, Andres Azuero, Bulent Turan, Mirjam Colette Kempf

Abstract read
In one paragraph

Article in Nursing (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pariya L FazeliSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
David E VanceSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Jeremy D DelgadilloDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.
Shakaye R HaaseDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.
Crystal Chapman LambertSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Brittany L BradleySchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Andres AzueroSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Bulent TuranDepartment of Psychology, Koc University, Istanbul, Turkey.
Mirjam Colette KempfSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.

Funding

Evaluation of Neurobiological Mechanisms Mediating the Effect of Immune Activation on Neurocognitive Impairment and the Role of Psychosocial Factors Among Women Living with HIVR01MH131177 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Andrea Norcini Pala, Pariya Fazeli Wheeler · 2022 to 2026
$3.3M
Examining the Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living with HIV (HEALTH-Cog)R01AG077997 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHEELER, PARIYA FAZELI · 2023 to 2025
$2.2M
The essentiality of serine and glycine for skeletal muscle regeneration in agingR01AG075059 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI THALACKER-MERCER, ANNA E. · 2022 to 2025
$1.5M
Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging with HIVR21AG076377 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHEELER, PARIYA FAZELI · 2022 to 2023
$520k
NIA NIH HHS R01 AG075059NIA NIH HHS R01 AG077997NIA NIH HHS R21 AG076377NIMH NIH HHS R01 MH131177
6 · The paper itself

Abstract

Purpose: Despite evidence that: 1) older people living with HIV (PLHIV) experience a high burden of stress that is associated with myriad poorer outcomes, 2) psychological resilience may buffer the negative effects of stress in older PLHIV, and 3) older PLHIV may possess lower levels of this protective factor than seronegative counterparts, little work has examined strategies to bolster resilience in older PLHIV. This article details the protocol for a pilot clinical trial examining the feasibility and efficacy of a theory-driven resilience intervention that has been adapted for older PLHIV. Patients and Methods: This study plans to randomize 100 older PLHIV aged 45+ with suboptimal HIV treatment management to either an intervention condition (i.e., Resilience Intervention for Successful Aging Enhancement [RISE+]) or an attention-matched control condition. Both arms include weekly one-hour in person group intervention sessions. The comprehensive assessment includes proximal mechanistic measures, (i.e., real-time measurement of resilience resources and stress reactivity and recovery via experience sampling method [ESM] text message-prompted online surveys) and health (i.e., psychological functioning and HIV outcomes) measures. Primary Aims focus on intervention effects on: the use of resilience resources and whether such increases drive improved affective stress reactivity and recovery (Aim 1) and distal health outcomes at three months (Aim 2). Conclusions: This study tests a novel resilience intervention among older PLHIV and has several strengths, including focusing on an at-risk and understudied population, rigorous examination of efficacy and mechanism, and utilizing an intervention with minimal facilitator involvement, which has implications for future scalability. Findings will identify intervention mechanisms and inform the development of potent and scalable interventions for building resilience in older PLHIV and other diverse populations of older adults.

Indexed as

agingHIV/AIDSpositive psychologypsychosocial interventionstress reduction

Identifiers

PMID40950841
PMCPMC12428870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.